Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
38.95
0.28 (0.72%)
At close: Aug 18, 2025, 3:59 PM
39.43
1.22%
After-hours: Aug 18, 2025, 07:31 PM EDT

Cytokinetics Revenue

Cytokinetics reported an annual revenue of $18.47M, reflecting a 145.34% growth. For the quarter ending June 30, 2025, Cytokinetics generated $66.77M in revenue.
Revenue (ttm)
18.47M
Revenue Growth
145.34%
Price / Sales Ratio
285.13
Revenue / Employee
37.1K
Employees
498
Market Cap
4.66B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 18.47M +145.34%
Dec 31, 2023 7.53M -92.04%
Dec 31, 2022 94.59M +34.30%
Dec 31, 2021 70.43M +26.15%
Dec 31, 2020 55.83M +107.79%
Dec 31, 2019 26.87M -14.71%
Dec 31, 2018 31.5M +135.64%
Dec 31, 2017 13.37M -87.44%
Dec 31, 2016 106.41M +271.30%
Dec 31, 2015 28.66M -38.95%
Dec 31, 2014 46.94M +53.16%
Dec 31, 2013 30.65M +305.45%
Dec 31, 2012 7.56M +88.98%
Dec 31, 2011 4M +55.22%
Dec 31, 2010 2.58M -96.84%
Dec 31, 2009 81.54M +556.51%
Dec 31, 2008 12.42M -8.82%
Dec 31, 2007 13.62M +335.63%
Dec 31, 2006 3.13M -64.91%
Dec 31, 2005 8.91M -33.70%
Dec 31, 2004 13.44M +27.09%
Dec 31, 2003 10.58M -7.19%
Dec 31, 2002 11.4M +34.61%
Dec 31, 2001 8.47M +Infinity%
Dec 31, 2000 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.